Trulieve Becomes First US Cannabis Company to List Medical Unit on NYSE
TRLV•Trulieve separated its federally compliant medical cannabis operations and began trading on the NYSE under TRLV, becoming the first U.S. cannabis company to list with 100% DEA-registered assets. The company supports 206 dispensaries and 3.5 million square feet of cultivation capacity, touting approximately 60% gross margins and planning expansion into Texas.
1. NYSE Listing of Medical Unit
Trulieve completed a corporate restructuring to ring-fence its medical cannabis operations and secured DEA registration, enabling its listing on the New York Stock Exchange. This historic milestone positions the company as the first U.S. cannabis operator to meet federal compliance requirements and trade on a major exchange.
2. Scale of Operations
The medical business comprises 206 DEA-registered dispensaries supported by approximately 3.5 million square feet of cultivation and production capacity across Florida, Pennsylvania, Georgia and West Virginia. These assets are fully separated from Trulieve’s adult-use operations to maintain federal compliance.
3. Financial Performance and Growth Plans
Trulieve’s medical unit reports gross margins near 60%, among the strongest in the sector, and highlights improved access to institutional capital and traditional banking services. Management is targeting expansion into Texas and other states as federal rescheduling momentum continues, aiming to fuel the next phase of U.S. market growth.
